Site icon OncologyTube

Talazoparib is Effective in Neoadjuvant Setting | Combine PARP-Inhibitors w Immune Checkpoint

Hope S. Rugo, MD, FAnnual Meeting, University of California, San Francisco explains Talazoparib is Effective in Neoadjuvant Setting | Combine PARP-Inhibitors w Immune Checkpoint at Annual Meeting 2018

Exit mobile version